Strategies to Improve Colonoscopy Preparation in Inflammatory Bowel Disease. A Systematic Review and Network Meta-analysis of Randomized Trials.

Abhirup Chatterjee, Sumanpreet Kaur, Anuraag Jena, Amol N Patil, Usha Dutta, Shaji Sebastian, Vishal Sharma
{"title":"Strategies to Improve Colonoscopy Preparation in Inflammatory Bowel Disease. A Systematic Review and Network Meta-analysis of Randomized Trials.","authors":"Abhirup Chatterjee, Sumanpreet Kaur, Anuraag Jena, Amol N Patil, Usha Dutta, Shaji Sebastian, Vishal Sharma","doi":"10.15403/jgld-5433","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aims: </strong>Colonoscopy has a vital role in the diagnosis of inflammatory bowel disease (IBD), as well as in the estimation of disease severity, monitoring response to therapy, and surveillance for neoplasia. We performed a systematic review of randomised trials of various bowel preparations for colonoscopy in IBD.</p><p><strong>Methods: </strong>We searched various electronic databases (PubMed, Embase, and CENTRAL) for studies reporting about the use of various strategies to improve colonoscopy preparation in IBD. We included only randomized clinical trials (RCTs). A network meta-analysis was done using a frequentist approach to compare the effectiveness of various bowel preparations. The risk of bias was assessed using Cochrane risk of bias tool 2.0. Other outcome parameters like compliance, tolerance, acceptance, and adverse effects were assessed qualitatively.</p><p><strong>Results: </strong>Seven RCTs reporting about 960 patients were included. On comparison with 4 liter (L) of poliethylen glycol (PEG), oral sulfate solution (OR=1.1, 95%CI: 0.65-1.86); PEG2L/Ascorbate (OR=0.98, 95%CI: 0.65-1.48); PEG1L (OR=1, 95%CI: 0.55-1.81); PEG2L plus bisacodyl (OR=1.08, 95%CI: 0.71-1.65); PEG4L plus simethicone (OR=1, 95%CI: 0.67-1.50); PEG/ sodium picosulfate and magnesium citrate (SPMC) 1.5L (OR=0.99, 95%CI: 0.55-1.78); SPMC 2L (OR=1.09, 95%CI: 0.61-1.97) had similar effectiveness. Three RCTs reported compliance, five RCTs reported tolerance, two studies reported patient acceptance and five RCTs reported data on the willingness of patients to repeat the procedure in the future. Low-volume preparations had better compliance, tolerance, acceptance, and willingness to repeat. No difference in additional outcomes like change in disease activity after colonoscopy, procedure-related outcomes after colonoscopy like cecal intubation rate, and change in electrolyte levels were found.</p><p><strong>Conclusion: </strong>Various bowel preparations had similar effectiveness in respect to colonoscopy preparation in IBD patients. Low-volume preparations have better compliance, tolerance, and acceptance. The systematic review was limited by a small number of included RCTs.</p>","PeriodicalId":94081,"journal":{"name":"Journal of gastrointestinal and liver diseases : JGLD","volume":"33 2","pages":"245-253"},"PeriodicalIF":0.0000,"publicationDate":"2024-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of gastrointestinal and liver diseases : JGLD","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15403/jgld-5433","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background and aims: Colonoscopy has a vital role in the diagnosis of inflammatory bowel disease (IBD), as well as in the estimation of disease severity, monitoring response to therapy, and surveillance for neoplasia. We performed a systematic review of randomised trials of various bowel preparations for colonoscopy in IBD.

Methods: We searched various electronic databases (PubMed, Embase, and CENTRAL) for studies reporting about the use of various strategies to improve colonoscopy preparation in IBD. We included only randomized clinical trials (RCTs). A network meta-analysis was done using a frequentist approach to compare the effectiveness of various bowel preparations. The risk of bias was assessed using Cochrane risk of bias tool 2.0. Other outcome parameters like compliance, tolerance, acceptance, and adverse effects were assessed qualitatively.

Results: Seven RCTs reporting about 960 patients were included. On comparison with 4 liter (L) of poliethylen glycol (PEG), oral sulfate solution (OR=1.1, 95%CI: 0.65-1.86); PEG2L/Ascorbate (OR=0.98, 95%CI: 0.65-1.48); PEG1L (OR=1, 95%CI: 0.55-1.81); PEG2L plus bisacodyl (OR=1.08, 95%CI: 0.71-1.65); PEG4L plus simethicone (OR=1, 95%CI: 0.67-1.50); PEG/ sodium picosulfate and magnesium citrate (SPMC) 1.5L (OR=0.99, 95%CI: 0.55-1.78); SPMC 2L (OR=1.09, 95%CI: 0.61-1.97) had similar effectiveness. Three RCTs reported compliance, five RCTs reported tolerance, two studies reported patient acceptance and five RCTs reported data on the willingness of patients to repeat the procedure in the future. Low-volume preparations had better compliance, tolerance, acceptance, and willingness to repeat. No difference in additional outcomes like change in disease activity after colonoscopy, procedure-related outcomes after colonoscopy like cecal intubation rate, and change in electrolyte levels were found.

Conclusion: Various bowel preparations had similar effectiveness in respect to colonoscopy preparation in IBD patients. Low-volume preparations have better compliance, tolerance, and acceptance. The systematic review was limited by a small number of included RCTs.

改善炎症性肠病结肠镜检查准备的策略。随机试验的系统回顾和网络 Meta 分析。
背景和目的:结肠镜检查在诊断炎症性肠病(IBD)、估计疾病严重程度、监测治疗反应和监测肿瘤方面发挥着重要作用。我们对用于 IBD 结肠镜检查的各种肠道制剂的随机试验进行了系统回顾:我们在多个电子数据库(PubMed、Embase 和 CENTRAL)中搜索了有关使用各种策略改善 IBD 结肠镜检查准备工作的研究报告。我们只纳入了随机临床试验(RCT)。我们采用频数主义方法进行了网络荟萃分析,以比较各种肠道准备工作的有效性。偏倚风险采用 Cochrane 偏倚风险工具 2.0 进行评估。对其他结果参数,如依从性、耐受性、接受度和不良反应进行了定性评估:结果:共纳入了 7 项 RCT,报告了约 960 名患者。与 4 升(L)聚乙二醇(PEG)、硫酸口服溶液(OR=1.1,95%CI:0.65-1.86);PEG2L/抗坏血酸(OR=0.98,95%CI:0.65-1.48);PEG1L(OR=1,95%CI:0.55-1.81);PEG2L 加比沙可啶(OR=1.08,95%CI:0.71-1.65);PEG4L 加西甲硅油(OR=1,95%CI:0.67-1.50);PEG/皮下硫酸钠和枸橼酸镁(SPMC)1.5L(OR=0.99,95%CI:0.55-1.78);SPMC 2L(OR=1.09,95%CI:0.61-1.97)的疗效相似。三项研究报告了依从性,五项研究报告了耐受性,两项研究报告了患者的接受程度,五项研究报告了患者今后是否愿意重复治疗的数据。低剂量制剂的依从性、耐受性、接受度和重复意愿都更好。结肠镜检查后疾病活动度的变化、结肠镜检查后与手术相关的结果(如盲肠插管率)以及电解质水平的变化等其他结果均无差异:结论:各种肠道制剂对 IBD 患者结肠镜检查的效果相似。低容量制剂具有更好的依从性、耐受性和接受性。由于纳入的研究性试验数量较少,该系统综述受到了一定的限制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信